Skip to content
10-Q

Quarterly Report

HALOZYME THERAPEUTICS, INC. HALO

0001159036-25-000045

← back to feed
Filed
Nov 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 27, 2025 117.6M sh
Shares Diluted Q3 2025 · Sep 30, 2025 122.33M sh
Shares Diluted Q3 2025 · Sep 30, 2025 124.45M sh
Shares Diluted Q3 2025 · Sep 30, 2024 130.13M sh
Shares Diluted Q3 2025 · Sep 30, 2024 129.53M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $342.37M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $5.54M
Capex Q3 2025 · Sep 30, 2024 $7.64M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $432.53M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $300.6M
Long Term Debt Q3 2025 · Sep 30, 2025 $800.07M
Long Term Debt Q3 2025 · Dec 31, 2024 $1.51B
Short Term Debt Q3 2025 · Sep 30, 2025 $710.69M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $419.67M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $115.85M
Stockholders Equity Q3 2025 · Sep 30, 2025 $503.92M
Stockholders Equity Q3 2025 · Jun 30, 2025 $332.75M
Stockholders Equity Q3 2025 · Dec 31, 2024 $363.82M
Stockholders Equity Q3 2025 · Sep 30, 2024 $452.7M
Stockholders Equity Q3 2025 · Jun 30, 2024 $289.42M
Stockholders Equity Q3 2025 · Dec 31, 2023 $83.81M
Current Liabilities Q3 2025 · Sep 30, 2025 $837.23M
Current Liabilities Q3 2025 · Dec 31, 2024 $139.1M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.72B
Total Liabilities Q3 2025 · Dec 31, 2024 $1.7B
Current Assets Q3 2025 · Sep 30, 2025 $1.33B
Current Assets Q3 2025 · Dec 31, 2024 $1.09B
Total Assets Q3 2025 · Sep 30, 2025 $2.22B
Total Assets Q3 2025 · Dec 31, 2024 $2.06B
Eps Diluted Q3 2025 · Sep 30, 2025 $1.43
Eps Diluted Q3 2025 · Sep 30, 2025 $3.68
Eps Diluted Q3 2025 · Sep 30, 2024 $1.05
Eps Diluted Q3 2025 · Sep 30, 2024 $2.37
Eps Basic Q3 2025 · Sep 30, 2025 $1.49
Eps Basic Q3 2025 · Sep 30, 2025 $3.80
Eps Basic Q3 2025 · Sep 30, 2024 $1.08
Eps Basic Q3 2025 · Sep 30, 2024 $2.42
Sga Expense Q3 2025 · Sep 30, 2025 $46.09M
Sga Expense Q3 2025 · Sep 30, 2025 $130.06M
Sga Expense Q3 2025 · Sep 30, 2024 $41.24M
Sga Expense Q3 2025 · Sep 30, 2024 $112.09M
Rd Expense Q3 2025 · Sep 30, 2025 $17.25M
Rd Expense Q3 2025 · Sep 30, 2025 $49.59M
Rd Expense Q3 2025 · Sep 30, 2024 $18.46M
Rd Expense Q3 2025 · Sep 30, 2024 $58.61M
Net Income Q3 2025 · Sep 30, 2025 $175.23M
Net Income Q3 2025 · Sep 30, 2025 $458.48M
Net Income Q3 2025 · Sep 30, 2024 $137.01M
Net Income Q3 2025 · Sep 30, 2024 $307.08M
Operating Income Q3 2025 · Sep 30, 2025 $217.92M
Operating Income Q3 2025 · Sep 30, 2025 $561.9M
Operating Income Q3 2025 · Sep 30, 2024 $163.2M
Operating Income Q3 2025 · Sep 30, 2024 $375.97M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $55.24M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $150M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $49.43M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $117.36M
Revenue Q3 2025 · Sep 30, 2025 $354.26M
Revenue Q3 2025 · Sep 30, 2025 $944.84M
Revenue Q3 2025 · Sep 30, 2024 $290.08M
Revenue Q3 2025 · Sep 30, 2024 $717.32M